Mereo BioPharma Announces Setrusumab 6-Month Phase 2b Data in Osteogenesis Imperfecta Selected for Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research (ASBMR) 2019 An Sep 4, 2019 08:00AM
Mereo BioPharma Appoints Richard Francis as Head of Pharmaceutical Development Jul 16, 2019 08:00AM
Mereo BioPharma (MREO) Announces Successful Type B Meeting with FDA, Outlines Accelerated Approval Pathway for Navicixizumab Jul 15, 2019 08:06AM
Mereo BioPharma Announces Successful Type B Meeting with U.S. FDA and Outlines Accelerated Approval Pathway for Navicixizumab in Advanced Ovarian Cancer Jul 15, 2019 08:00AM
Mereo BioPharma Group plc (“Mereo” or the “Company” or the “Group”) Update on Etigilimab (TIGIT) Partnership Jun 13, 2019 08:00AM


May 30, 2019 05:47AM UPDATE: Mereo BioPharma (MREO) Reports Positive Early 6 Month Data from Open Label Arm of Phase 2b Clinical Study of BPS-804 (setrusumab)
May 30, 2019 02:00AM Mereo BioPharma Group plc Announces Positive Early 6 Month Data from the Open Label Arm of the Phase 2b Clinical Study in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with the
May 3, 2019 12:09PM Mereo BioPharma Group plc (“Mereo” or the “Company” or the “Group”) Intention to Purchase Shares by Trustee of Employee Benefit Trust
Apr 26, 2019 08:00AM Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019
Apr 26, 2019 08:00AM Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019
Apr 24, 2019 09:30AM Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Admission to trading on AIM of New Shares and initiation of trading on Nasdaq of American Depositary Shares
Apr 24, 2019 09:30AM Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Admission to trading on AIM of New Shares and initiation of trading on Nasdaq of American Depositary S
Jan 25, 2019 06:13AM Mereo Publicly Files Registration Statement on Form F-4 with U.S. Securities and Exchange Commission
Dec 10, 2018 02:00AM Mereo BioPharma to Present at The BMO Prescriptions for Success Healthcare Conference on 12 December 2018
Dec 5, 2018 08:10AM Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals